Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Oct 18:16:e29.
doi: 10.15420/icr.2021.20. eCollection 2021 Apr.

Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy?

Affiliations
Review

Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy?

Zaccharie Tyler et al. Interv Cardiol. .

Abstract

Left ventricular endomyocardial biopsy (EMB) is an essential tool in the management of myocarditis and is conventionally performed via transfemoral access (TFA). Transradial access EMB (TRA-EMB) is a novel alternative and the authors sought to determine its safety and feasibility by conducting a systematic review of the literature. Medline was searched in 2020, and cohort demographics, procedural details and complications were extracted from selected studies. Four observational studies with a combined total of 496 procedures were included. TRA-EMB was most frequently performed with a sheathless MP1 guide catheter via the right radial artery. The most common complication was pericardial effusion (up to 11% in one study), but pericardial drainage for tamponade was rare (one reported case). Death and mitral valve damage have not been reported. TRA-EMB was successful in obtaining samples in 99% of reported procedures. The authors concluded that TRA-EMB is a safe and feasible alternative to TFA-EMB and the most common complication is uncomplicated pericardial effusion.

Keywords: Transradial approach; biopsy; myocarditis.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflicts of interest to declare. Availability of data: Data are available on request from the corresponding author. All authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.

Figures

Figure 1:
Figure 1:. Study Selection
Figure 2:
Figure 2:. Complications Reported in Association with Transradial Access Endomyocardial Biopsy

References

    1. Yilmaz A, Kindermann I, Kindermann M et al. Comparative evaluation of left and right ventricular endomyocardial biopsy. Circulation. 2010;122:900–9. doi: 10.1161/CIRCULATIONAHA.109.924167. - DOI - PubMed
    1. Frustaci A, Pieroni M, Chimenti C. atl>The role of endomyocardial biopsy in the diagnosis of cardiomyopathies. Ital Hear J. 2002;3:348–53. - PubMed
    1. Chimenti C, Frustaci A. atl>Contribution and risk of left ventricular endomyocardial biopsy in patients with cardiomyopathies: a retrospective study over a 28-year period. Circulation. 2013;128:1531–41. doi: 10.1161/CIRCULATIONAHA.114.009355. - DOI - PubMed
    1. Seferović PM, Tsutsui H, McNamara DM et al. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society position statement on endomyocardial biopsy. Eur J Heart Fail. 2021;23:854–71. doi: 10.1002/ejhf.2190. - DOI - PubMed
    1. Mitchell MD, Hong JA, Lee BY et al. Systematic review and cost-benefit analysis of radial artery access for coronary angiography and intervention. Circ Cardiovasc Qual Outcomes. 2012;5:454–62. doi: 10.1161/CIRCOUTCOMES.112.965269. - DOI - PMC - PubMed

LinkOut - more resources